Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Carfilzomib, Cyclophosphamide and Dexamethasone in Relapsed Multiple Myeloma
NCT02597062Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jul 2016
- Primary completion
- Jun 2019
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM), sponsored by Canadian Cancer Trials Group. Started Jul 2016; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02597062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597062.